You are here: Urology Textbook > Drugs in Urology > Anticholinergics > Trospium chloride
Side Effects, Contraindications and Dosage
- Anticholinergics (1/9): general pharmacology
- Anticholinergics (2/9): trospium chloride
- Anticholinergics (3/9): oxybutynin
- Anticholinergics (4/9): tolterodine
- Anticholinergics (5/9): fesoterodine
- Anticholinergics (6/9): propiverine
- Anticholinergics (7/9): darifenacin
- Anticholinergics (8/9): solifenacin
- Anticholinergics (9/9): butylscopolamine
Trospium chloride is a quaternary amine with anticholinergic properties, there is a high affinity for M1 and M3 muscarinic receptors. Trospium chloride is used to treat enuresis, urge incontinence and neurogenic lower urinary tract dysfunction. Review literature: (Ouslander, 2004) (Yoshimura and Chancellor, 2002).
For mechanism of action, side effects, contraindications and interactions of anticholinergics see section anticholinergics.
Pharmacokinetics of Trospium Chloride:
Trospium chloride is a quaternary amine, it has a very low penetrance of the blood-brain barrier and thus cerebral side effects are not as prominent. Half live 5–20 h. Elimination: mainly unchanged renal excretion.
Dosage of Trospium Chloride:
5 mg 1-1-1 to 15 mg 1-1-1. 20 mg is the maximum daily dosage of trospium chloride in patients with renal clearance below 30 ml/min.
Brand Names of Trospium Chloride
Sanctura, Tropez OD, Trosec, Regurin, Flotros, Spasmex, Spasmolyt.
| Anticholinergics | Index | Pharmacology |
Index: 1–9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
References for Trospium
Ouslander 2004 OUSLANDER, J. G.: Management of overactive bladder.In: N Engl J Med
350 (2004), Nr. 8, S. 786–99
Yoshimura und Chancellor 2002 YOSHIMURA, N. ;
CHANCELLOR, M. B.:
Current and future pharmacological treatment for overactive bladder.
In: J Urol
168 (2002), Nr. 5, S. 1897–913
Deutsche Version: Trospium Chlorid